Amlodipine - Clinical Pharmacology 12.1 Amlodipine Mechanism of Action Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle
In cells containing mitochondria, ALA is reduced in an NADH-dependent reaction with lipoamide dehydrogenase to form dihydrolipoic acid (DHLA), whereas in cells that lack mitochondria, ALA can instead be reduced to DHLA via NADPH with glutathione (GSH) and thioredoxin reductases (Jones et al., 2002)
Clinical use should remain conservative and individualized
It is possible that the cumulative or progressive dosing regimen contributed to the outcome, particularly given that a dose of 10 mg/kg has been associated with adverse neurological effects in other experimental settings (Mohammadpanah et al., 2023
The ratio of ruthenium released from the nanoparticles was calculated as the percentage of cumulative ruthenium in the dialysate relative to the total amount of ruthenium present in the nanoparticles
